Revvity (RVTY) Following Its Margin Story Is The Stock Already Fully Valued

Simply Wall St.

Sep 03

Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals. Revvity’s...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/news/2664843969"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664843969\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664843969?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","is_english":true,"pubTime":"2026-09-03 00:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664843969","market":"us","top_or_hot":-1,"title":"Revvity (RVTY) Following Its Margin Story Is The Stock Already Fully Valued","media":"Simply Wall St.","content":"<div>\n<p>Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals. Revvity’s...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-rvty-following-its-margin-story-is-the-stock-already\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Revvity (RVTY) Following Its Margin Story Is The Stock Already Fully Valued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRevvity (RVTY) Following Its Margin Story Is The Stock Already Fully Valued\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-03 00:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-rvty-following-its-margin-story-is-the-stock-already><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals. Revvity’s...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-rvty-following-its-margin-story-is-the-stock-already\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64QTZ34.USD","symbol_name":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-rvty-following-its-margin-story-is-the-stock-already","article_id":"2664843969","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-rvty-following-its-margin-story-is-the-stock-already","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2664843969","pubTimestamp":1788366543,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals.\nRevvity’s share price has climbed 25.25% over the past 90 days and 28.98% year to date, while its 1 year total shareholder return of 44.46% contrasts with a weaker 5 year total shareholder return. This suggests that recent momentum has picked up after a tougher longer stretch.\nCompare Revvity’s renewed...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","BK4588":"碎股","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4585":"ETF&股票定投概念","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","BK4121":"生命科学工具和服务","RVTY":"REVVITY INC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC"},"translate_title":"Revvity (RVTY) 根据其利润率故事，这只股票已经被充分估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVTY":1.5,"DCF":1},"content_text":"Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals. Revvity’s share price has climbed 25.25% over the past 90 days and 28.98% year to date, while its 1 year total shareholder return of 44.46% contrasts with a weaker 5 year total shareholder return. This suggests that recent momentum has picked up after a tougher longer stretch. Compare Revvity’s renewed momentum with a curated set of other companies showing similar earnings and price action by scanning the 50 high quality undervalued stocks, which may still be flying under the radar. The question now is whether Revvity’s sharp rebound reflects a healthier earnings outlook or a swing in sentiment that has run ahead of fundamentals. The answer starts to emerge once you compare that move with valuation. AdvertisementMost Popular Narrative: 4.6% Overvalued Revvity’s last close at $126.59 sits modestly above the narrative fair value of $121.07. This frames the recent share price strength against projected cash flows and profitability.  Ongoing shift in product mix toward higher-margin, software-enabled and consumables-driven offerings (e.g., SaaS Signals, reagents, new IDS i20 platform), along with structural cost actions, are expected to materially expand operating and net margins, with 2026 set to start at a higher 28% operating margin baseline.  Read the complete narrative. Want to see what sits behind that higher margin starting point? The narrative focuses on measured revenue growth, faster profit expansion and a future earnings multiple that has been carefully adjusted lower. This combination is what supports that fair value mark for Revvity. Result: Fair Value of $121.07 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, investors still need to weigh risks such as weaker academic and government funding, or tighter healthcare pricing that could pressure Revvity’s diagnostics volumes and margins. Find out about the key risks to this Revvity narrative. Revvity Valuation Check: DCF Points the Other Way There is a twist when you look at Revvity through the SWS DCF model. On this view, the stock at $126.59 screens as undervalued compared with an estimated future cash flow value of $135.21. That is very different from the 4.6% overvalued narrative fair value of $121.07. Both approaches use the same company, but they reward different things. The narrative view leans on earnings, margins and multiples. The DCF view focuses on long term cash generation and the discount rate. Which lens do you think better reflects how you expect Revvity to perform over time? Look into how the SWS DCF model arrives at its fair value. RVTY Discounted Cash Flow as at Sep 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Revvity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps If this combination of optimism and caution around Revvity leaves you undecided, consider reviewing the data yourself soon, before sentiment shifts further. You can evaluate both sides of the story in one place by checking the 2 key rewards and 1 important warning sign. Looking for more investment ideas beyond Revvity? If you are serious about finding the next opportunity before it becomes crowded, use the Simply Wall St Screener to compare Revvity with other stocks on your watchlist.  Spot potential bargains early by scanning the 50 high quality undervalued stocks that combine quality fundamentals with more modest pricing. Secure your income stream by reviewing the 12 dividend fortresses that aim to pair higher yields with resilient payout histories. Reduce portfolio shocks by focusing on the 74 resilient stocks with low risk scores that score well on financial strength and business stability.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}